Analyze Diet
Asian spine journal2014; 8(5); 680-683; doi: 10.4184/asj.2014.8.5.680

Drop metastasis of adrenocorticotropic hormone-producing pituitary carcinoma to the cauda equina.

Abstract: The diagnosis of pituitary carcinoma cannot be made easily histologically, and most cases of pituitary carcinoma are diagnosed only after the clinical detection of metastasis. Distant metastasis of pituitary tumor occurs in 0.1% to 0.2% of cases and has been reported in the liver, bone and central nervous system, with only one case of metastasis to the cauda equine reported. This study describes a rare case of the drop metastasis of adrenocorticotropic hormone-producing pituitary adenocarcinoma to the cauda equina, causing cauda equina syndrome.
Publication Date: 2014-10-18 PubMed ID: 25346823PubMed Central: PMC4206820DOI: 10.4184/asj.2014.8.5.680Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses a rare case of pituitary cancer spreading (metastasizing) to the cauda equina, a bundle of nerve roots at the lower end of the spinal cord, causing cauda equina syndrome.

Introduction and Background

  • The research paper begins by noting that diagnosing pituitary carcinoma (a type of brain tumor) can be quite challenging from a histological perspective, meaning it’s difficult to identify using microscopic investigation of tissue changes. This often results in cases being confirmed only after metastasis (the spread of cancer cells to different parts of the body) is clinically detected.
  • The article states that distant metastasis of pituitary tumors is relatively rare, occurring in roughly 0.1% to 0.2% of cases. These metastases have been documented in various organs such as the liver, bones, and central nervous system.
  • The authors point out that there’s had been only one previous report of metastasis to the cauda equina. The cauda equina, named because of its resemblance to a horse’s tail, is a cluster of nerve roots at the lower end of the vertebral column.

Case Profile

  • The primary focus of the study is to describe a unique case in which a patient with Adrenocorticotropic hormone (ACTH)-producing pituitary adenocarcinoma experienced metastasis to the cauda equina.
  • ACTH is a hormone produced in the pituitary gland that stimulates the adrenal glands to release a hormone called cortisol. Overproduction of ACTH can lead to a form of pituitary news called pituitary adenomas, which can become cancerous and develop into pituitary carcinomas.
  • In this particular case, the metastasis resulted in cauda equina syndrome. This is a serious neurological condition that causes loss of function of nerve roots of the cauda equina. Common symptoms might include lower back pain, weakness of the muscles of the lower extremities, and bowel or bladder dysfunction.

Treatment and Conclusion

  • The study does not specify the course of treatment that was followed for this patient or the eventual outcome. However, the report of this case helps in expanding medical understanding and knowledge regarding the potential for rare metastasis sites in pituitary carcinoma.
  • Furthermore, the case emphasizes the need for comprehensive investigation when diagnosing pituitary carcinoma, considering its potential for metastasis which might cause severe neuromuscular conditions like cauda equina syndrome.

Cite This Article

APA
Takeuchi K, Hagiwara Y, Kanaya K, Wada K, Shiba M, Kato Y. (2014). Drop metastasis of adrenocorticotropic hormone-producing pituitary carcinoma to the cauda equina. Asian Spine J, 8(5), 680-683. https://doi.org/10.4184/asj.2014.8.5.680

Publication

ISSN: 1976-1902
NlmUniqueID: 101314177
Country: Korea (South)
Language: English
Volume: 8
Issue: 5
Pages: 680-683

Researcher Affiliations

Takeuchi, Kenichi
  • Department of Orthopaedic Surgery, Tokyo Women's Medical University, Tokyo, Japan.
Hagiwara, Yoko
  • Department of Orthopaedic Surgery, Tokyo Women's Medical University, Tokyo, Japan.
Kanaya, Koichi
  • Department of Orthopaedic Surgery, Tokyo Women's Medical University, Tokyo, Japan.
Wada, Keiji
  • Department of Orthopaedic Surgery, Tokyo Women's Medical University, Tokyo, Japan.
Shiba, Masahiro
  • Department of Orthopaedic Surgery, Tokyo Women's Medical University, Tokyo, Japan.
Kato, Yoshiharu
  • Department of Orthopaedic Surgery, Tokyo Women's Medical University, Tokyo, Japan.

Conflict of Interest Statement

No potential conflict of interest relevant to this article was reported.

References

This article includes 9 references
  1. van der Klaauw AA, Kienitz T, Strasburger CJ, Smit JW, Romijn JA. Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature.. Pituitary 2009;12:57–69.
    pubmed: 18176844
  2. Pernicone PJ, Scheithauer BW, Sebo TJ. Pituitary carcinoma: a clinicopathologic study of 15 cases.. Cancer 1997;79:804–812.
    pubmed: 9024719
  3. Chow TS, McCutcheon IE. The surgical treatment of metastatic spinal tumors within the intradural extramedullary compartment.. J Neurosurg 1996;85:225–230.
    pubmed: 8755750
  4. Jacobs WB, Perrin RG. Evaluation and treatment of spinal metastases: an overview.. Neurosurg Focus 2001;11:e10.
    pubmed: 16463993
  5. Schick U, Marquardt G, Lorenz R. Intradural and extradural spinal metastases.. Neurosurg Rev 2001;24:1–5.
    pubmed: 11339461
  6. Kouhara H, Tatekawa T, Koga M. Intracranial and intraspinal dissemination of an ACTH-secreting pituitary tumor.. Endocrinol Jpn 1992;39:177–184.
    pubmed: 1327728
  7. Lubke D, Saeger W. Carcinomas of the pituitary: definition and review of the literature.. Gen Diagn Pathol 1995;141:81–92.
    pubmed: 8548598
  8. Thapar K, Kovacs K, Scheithauer BW. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody.. Neurosurgery 1996;38:99–106.
    pubmed: 8747957
  9. Taya K, Terao T, Nakazaki H. Intracranial metastasis of pituitary adenoma: a case report.. No Shinkei Geka 2004;32:279–284.
    pubmed: 15148803